139 related articles for article (PubMed ID: 6186559)
1. Aspects of humoral immunity in a prospective study of Type I (insulin-dependent) diabetic subjects treated with insulins of different purity.
Iavicoli M; Ventriglia L; Di Mario U; Galfo C; Andreani D
Diabetologia; 1983 Jan; 24(1):26-9. PubMed ID: 6186559
[TBL] [Abstract][Full Text] [Related]
2. Semisynthetic human insulin: biologic and immunologic activity in newly treated diabetic subjects during a six-month follow-up.
Iavicoli M; Di Mario U; Coronel GA; Dawud AM; Arduini P; Leonardi M
Diabetes Care; 1984; 7(2):128-31. PubMed ID: 6376008
[TBL] [Abstract][Full Text] [Related]
3. The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
Di Mario U; Ventriglia L; Iavicoli M; Guy K; Andreani D
Clin Exp Immunol; 1983 Jun; 52(3):575-80. PubMed ID: 6603299
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of circulating immune complexes in lupus nephritis by solid phase C1q and conglutinin binding assays.
Yoshida H; Muso E; Inoue S; Furukawa F; Sekita K; Kawai C; Hamashima Y
Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):293-300. PubMed ID: 6611433
[No Abstract] [Full Text] [Related]
5. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
Dorchy H; Duchateau J; Bosson D; D'Hooge D
Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
[TBL] [Abstract][Full Text] [Related]
6. Humoral immunity in type 1 diabetes mellitus: a prospective study.
Borsey DQ; Di Mario U; Irvine WJ; Gray RS; Guy K; Weston J; Peutherer J; Duncan LJ
J Clin Lab Immunol; 1983 May; 11(1):9-15. PubMed ID: 6876143
[TBL] [Abstract][Full Text] [Related]
7. Measurement of serum antibodies to C1q and conglutinin in rabbits following feeding with cows' milk and in normal human serum.
Hanglow AC; Welsh CJ; Coombs RR
Adv Exp Med Biol; 1987; 216B():1317-23. PubMed ID: 3501233
[No Abstract] [Full Text] [Related]
8. Interference by rheumatoid factor and C1q in the detection of IgG complexes: studies of model systems by ELISA.
Wager O; Lindstrøm P
Scand J Immunol; 1982 Mar; 15(3):319-28. PubMed ID: 6979777
[TBL] [Abstract][Full Text] [Related]
9. Immune complexes in newly diagnosed insulin-dependent (type I) diabetics.
Irvine WJ; Di Mario U; Guy K; Feek CM; Gray RS; Duncan LJ
J Clin Lab Immunol; 1978 Nov; 1(3):183-6. PubMed ID: 387959
[TBL] [Abstract][Full Text] [Related]
10. Circulating immune complexes in patients with diabetes mellitus.
Abrass CK; Heber D; Lieberman J
Clin Exp Immunol; 1983 Apr; 52(1):164-72. PubMed ID: 6305541
[TBL] [Abstract][Full Text] [Related]
11. Incidence of circulating immune complexes in patients with acute poststreptococcal glomerulonephritis and in patients with streptococcal impetigo.
Mezzano S; Olavarría F; Ardiles L; López MI
Clin Nephrol; 1986 Aug; 26(2):61-5. PubMed ID: 3530567
[TBL] [Abstract][Full Text] [Related]
12. Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.
Tun RY; Peakman M; Alviggi L; Hussain MJ; Lo SS; Shattock M; Pyke DA; Bottazzo GF; Vergani D; Leslie RD
BMJ; 1994 Apr; 308(6936):1063-8. PubMed ID: 8173426
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes in diabetics: the influence of sex, age, duration of disease and type of treatment.
Di Mario U; Irvine WJ; Guy K; Borsey DQ; Iavicoli M; Ventriglia L
J Clin Lab Immunol; 1983 May; 11(1):17-20. PubMed ID: 6348294
[TBL] [Abstract][Full Text] [Related]
14. Immune abnormalities in diabetic patients not requiring insulin at diagnosis.
Di Mario U; Irvine WJ; Borsey DQ; Kyner JL; Weston J; Galfo C
Diabetologia; 1983 Nov; 25(5):392-5. PubMed ID: 6360778
[TBL] [Abstract][Full Text] [Related]
15. Association of C1q- and conglutinin-binding immune complexes with high consumption of alpha-2-macroglobulin in synovial fluids of patients with rheumatoid arthritis.
Borth W; Menzel JE
Int Arch Allergy Appl Immunol; 1984; 75(1):92-6. PubMed ID: 6204949
[TBL] [Abstract][Full Text] [Related]
16. Isolation of circulating immune complexes by conglutinin and separation of antigen from dissociated complexes by immobilized protein A.
Gupta RC; Tan EM
Clin Exp Immunol; 1981 Oct; 46(1):9-19. PubMed ID: 7337970
[TBL] [Abstract][Full Text] [Related]
17. Immune complexes in diabetes mellitus: studies of complement utilisation and tissue deposition.
Charlesworth JA; Campbell LV; Catanzaro R; Pussell BA; Pasterfield GV; Peake P
J Clin Lab Immunol; 1982 Sep; 8(3):163-8. PubMed ID: 6752415
[No Abstract] [Full Text] [Related]
18. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
19. Effects of species of origin, purification levels, and formulation on insulin immunogenicity.
Fineberg SE; Galloway JA; Fineberg NS; Goldman J
Diabetes; 1983 Jul; 32(7):592-9. PubMed ID: 6345238
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
